Robert Joseph Ball Purchases 3,300 Shares of Shoulder Innovations (NYSE:SI) Stock

by · The Markets Daily

Shoulder Innovations, Inc. (NYSE:SI – Get Free Report) CEO Robert Joseph Ball bought 3,300 shares of the business’s stock in a transaction on Thursday, December 11th. The shares were acquired at an average price of $14.83 per share, for a total transaction of $48,939.00. Following the completion of the transaction, the chief executive officer owned 114,557 shares in the company, valued at approximately $1,698,880.31. This trade represents a 2.97% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Robert Joseph Ball also recently made the following trade(s):

  • On Friday, December 12th, Robert Joseph Ball purchased 3,900 shares of Shoulder Innovations stock. The shares were acquired at an average cost of $14.89 per share, with a total value of $58,071.00.

Shoulder Innovations Price Performance

NYSE SI traded up $0.12 during trading hours on Monday, hitting $14.49. The company’s stock had a trading volume of 36,567 shares, compared to its average volume of 112,664. Shoulder Innovations, Inc. has a twelve month low of $10.92 and a twelve month high of $17.94. The stock has a fifty day moving average of $13.43.

Shoulder Innovations (NYSE:SI – Get Free Report) last issued its earnings results on Tuesday, November 11th. The company reported ($0.48) EPS for the quarter, missing the consensus estimate of ($0.37) by ($0.11). The business had revenue of $11.76 million for the quarter, compared to the consensus estimate of $9.99 million. Sell-side analysts expect that Shoulder Innovations, Inc. will post -0.56 EPS for the current fiscal year.

Wall Street Analyst Weigh In

SI has been the topic of several analyst reports. BTIG Research reissued a “buy” rating and issued a $23.00 target price on shares of Shoulder Innovations in a research note on Tuesday, September 9th. Piper Sandler reiterated an “overweight” rating and issued a $18.00 price target on shares of Shoulder Innovations in a research report on Wednesday, November 12th. Zacks Research upgraded shares of Shoulder Innovations to a “hold” rating in a report on Tuesday, August 26th. The Goldman Sachs Group started coverage on shares of Shoulder Innovations in a research note on Monday, August 25th. They issued a “buy” rating and a $20.00 target price for the company. Finally, Morgan Stanley lifted their price target on shares of Shoulder Innovations from $18.00 to $23.00 and gave the stock an “overweight” rating in a research report on Tuesday, December 2nd. Five investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $20.60.

Read Our Latest Stock Analysis on Shoulder Innovations

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of SI. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of Shoulder Innovations in the third quarter valued at approximately $28,000. Rhumbline Advisers acquired a new position in Shoulder Innovations in the 3rd quarter worth $54,000. Board of Trustees of The Leland Stanford Junior University bought a new position in Shoulder Innovations during the 3rd quarter worth about $170,000. Bank of America Corp DE bought a new position in Shoulder Innovations during the 3rd quarter worth about $322,000. Finally, Monashee Investment Management LLC acquired a new stake in shares of Shoulder Innovations in the 3rd quarter valued at about $502,000.

About Shoulder Innovations

(Get Free Report)

We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.

Featured Articles